Literature DB >> 14612929

Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements.

Nobuo Kondoh1, Akiyuki Hada, Akihide Ryo, Masahiro Shuda, Masaaki Arai, Osamu Matsubara, Fumihiro Kimura, Toru Wakatsuki, Mikio Yamamoto.   

Abstract

The expression of Galectin-1 (Gal-1) mRNA was activated in primary hepatocellular carcinomas (HCCs) compared to matched non-tumorous liver tissues. To elucidate the mechanism of Gal-1 activation in HCC cells, DNA methylation encompassing the transcriptional start site (-165/+151) was examined. Among 12 CpG dinucleotides on both DNA strands, those at positions -116, -109, -52, -41, -36, +35 and +43 were preferentially methylated in non-tumorous liver tissue, while hypomethylated in the matched HCC tissue. Transient transfection of a series of deleted GAL-1 promoters revealed that both an upstream (-57/-31) and a downstream (+10/+57) elements accounted for efficient promoter activity. Electrophoretic mobility shift assay of the upstream element (-63/-30) using nuclear extracts from three HCC cell lines (HLF, HuH7 and HepG2) and normal liver cells revealed at least two complexes (alpha and (beta) interacted with the upstream element in all of the nuclear extracts. Competition experiments revealed that the complex beta preferentially attached to the upstream element harboring unmethylated CpGs. On the other hand, at least three complexes (I, II and III) interacted with the downstream element in all of the nuclear extracts. Competition experiments revealed that complex I specifically attached to the downstream element harboring unmethylated CpG at +35. Furthermore, a DNase I protection assay revealed that a methylation-associated conformational alteration occurred near the CpG site at +35 in HLF cells. Thus, the specific interaction of methylation-sensitive factors to the upstream and downstream elements may be essential for the activation of the Gal-1 gene in HCC cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612929

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

Review 1.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

2.  O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.

Authors:  Raghothama Chaerkady; Paul J Thuluvath; Min-Sik Kim; Anuradha Nalli; Perumal Vivekanandan; Jessica Simmers; Michael Torbenson; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2008-07-18       Impact factor: 3.988

3.  Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.

Authors:  Daniela Spano; Roberta Russo; Vittorio Di Maso; Natalia Rosso; Luigi M Terracciano; Massimo Roncalli; Luigi Tornillo; Mario Capasso; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2009-12-21       Impact factor: 6.354

4.  Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.

Authors:  Jie Chen; Su-Jun Zhou; Yun Zhang; Guo-Qiang Zhang; Tian-Zhou Zha; Yi-Zhong Feng; Kai Zhang
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

5.  Correlation analysis of liver tumor-associated genes with liver regeneration.

Authors:  Cun-Shuan Xu; Shou-Bing Zhang; Xiao-Guang Chen; Salman Rahman
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

6.  Differential expression of genes during aflatoxin B(1)-induced hepatocarcinogenesis in tree shrews.

Authors:  Yuan Li; Da-Fang Wan; Jian-Jia Su; Ji Cao; Chao Ou; Xiao-Kun Qiu; Ke-Chen Ban; Chun Yang; Liu-Liang Qin; Dan Luo; Hui-Fen Yue; Li-Sheng Zhang; Jian-Ren Gu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 7.  Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.

Authors:  María L Bacigalupo; Malena Manzi; Gabriel A Rabinovich; María F Troncoso
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

8.  Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.

Authors:  Tamara Potikha; Orit Pappo; Lina Mizrahi; Devorah Olam; Sebastián M Maller; Gabriel A Rabinovich; Eithan Galun; Daniel S Goldenberg
Journal:  FASEB J       Date:  2019-03-21       Impact factor: 5.834

9.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

Review 10.  Immunotherapy for liver tumors: present status and future prospects.

Authors:  Pablo Matar; Laura Alaniz; Viviana Rozados; Jorge B Aquino; Mariana Malvicini; Catalina Atorrasagasti; Manuel Gidekel; Marcelo Silva; O Graciela Scharovsky; Guillermo Mazzolini
Journal:  J Biomed Sci       Date:  2009-03-06       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.